Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ACTRN12626001192370) titled 'Botulinum type A neurotoxin (Btx-A) for residual limb pain after major lower limb amputation' on Sept. 24.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Randomised controlled trial
Masking: Blinded (masking used)
Assignment: Parallel
Primary Sponsor: Auckland University of Technology
Condition:
Residual limb pain after major lower limb amputation
Residual limb pain after major lower limb amputation
Anaesthesiology - Pain management
Physical Medicine / Rehabilitation - Other physical medicine / rehabilitation
Neurological - Other neurological disorders
Intervention:
Treatment as ...